SUMMARY
Trihexyphenidyl
Hydrochloride
Tablets USP
Rx only
Trihexyphenidyl hydrochloride is a synthetic antispasmodic drug available in the following forms: Tablets, 2 mg and 5 mg.
This drug is indicated as an adjunct in the treatment of all forms of parkinsonism (post-encephalitic, arteriosclerotic, and idiopathic). It is often useful as adjuvant therapy when treating these forms of parkinsonism with levodopa. Additionally, it is indicated for the control of extrapyramidal disorders caused by central nervous system drugs such as the dibenzoxazepines, phenothiazines, thioxanthenes, and butyrophenones.
|
NEWS HIGHLIGHTS
Published Studies Related to Trihexyphenidyl
Pilot study on trihexyphenidyl in the treatment of dystonia in children with cerebral palsy. [2009.02]
The aim of this study was to assess trihexyphenidyl in reducing overall dystonia, improving upper limb function, and achieving goals in children with dystonic cerebral palsy. A randomized, double-blinded, placebo-controlled, crossover trial was conducted with 16 participants at a tertiary children's hospital...
Clinical Trials Related to Trihexyphenidyl
Childhood Hypertonia of Central Origin: A Trial of Anticholinergic Treatment Effects [Completed]
This study is an open-label trial of trihexyphenidyl in children with upper extremity
dystonia due to cerebral palsy. It is hypothesized that trihexyphenidyl in doses up to
0. 75mg/kg/day would be well-tolerated and show significant changes on the Melbourne scale of
upper extremity function.
Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD) [Not yet recruiting]
This study was designed to evaluate the pharmacokinetic profile, safety and efficacy in
Parkinson's Disease patients.
|
|
|
|
Page last updated: 2009-02-07
|
